专题：Hidradenitis Suppurativa and Treatments

This cluster of papers focuses on the treatment, pathogenesis, and comorbidities of Hidradenitis Suppurativa (HS), also known as Acne Inversa. It covers topics such as inflammatory pathways, genetic susceptibility, metabolic syndrome, and the impact of HS on quality of life. The cluster also discusses various therapeutic approaches including immunosuppressive therapy and TNF-alpha inhibitors.
最新文献
Enfortumab Vedotin plus Pembrolizumab as Perioperative Therapy

article Full Text OpenAlex

Endovascular treatment of hemorrhoids with foam sclerotherapy: a new outpatient strategy for hemorrhoidal disease using automated microfoam preparation system

article Full Text OpenAlex

Ultraviolet-Induced Fluorescence Dermatoscopy (UVFD) features in Porokeratosis: Findings from a Multicenter Retrospective Study

article Full Text OpenAlex

Metronidazole is an effective method of analgesia following haemorrhoidectomy: a systematic review and meta-analysis

article Full Text OpenAlex

Advances in the pathogenesis of rosacea

article Full Text OpenAlex

Dupilumab-induced generalized pustular psoriasis ina Chinese woman with atopic dermatitis

article Full Text OpenAlex

Dissecting Cellulitis of the Scalp Associated With Dupilumab: A Paradoxical Neutrophilic Reaction

article Full Text OpenAlex

Clinical Trial Endpoints for Perianal Fistulizing Crohn's Disease

article Full Text OpenAlex

Relationship between recurrent colorectal cancer and EGFR inhibitor-induced dermatological side effects: a focus on paronychia

article Full Text OpenAlex

From signal to strategy: a disproportionality analysis of dupilumab-associated rosacea in FAERS with a summary of reported clinical cases

article Full Text OpenAlex

近5年高被引文献
Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials

article Full Text OpenAlex 276 FWCI79.9069

Antimicrobial Potential of Curcumin: Therapeutic Potential and Challenges to Clinical Applications

review Full Text OpenAlex 252 FWCI17.2168

Pyoderma Gangrenosum: An Updated Literature Review on Established and Emerging Pharmacological Treatments

review Full Text OpenAlex 204 FWCI29.6212

Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials

article Full Text OpenAlex 134 FWCI74.2703

The Genomic Architecture of Hidradenitis Suppurativa—A Systematic Review

review Full Text OpenAlex 115 FWCI16.3166

IRAK4 degrader in hidradenitis suppurativa and atopic dermatitis: a phase 1 trial

article Full Text OpenAlex 100 FWCI28.9518

Hidradenitis suppurativa

review Full Text OpenAlex 91 FWCI197.0385

Racial disparities in dermatology

article Full Text OpenAlex 88 FWCI26.2138

Janus kinase 1 inhibitor INCB054707 for patients with moderate‐to‐severe hidradenitis suppurativa: results from two phase II studies*

article Full Text OpenAlex 82 FWCI16.4901

Hidradenitis suppurativa: new insights into disease mechanisms and an evolving treatment landscape

article Full Text OpenAlex 78 FWCI22.7743